PLIF

Amplify™ Surgical, Inc. Announces First Surgical Cases with dualX™ Dual Expanding Interbody Fusion System

Retrieved on: 
Wednesday, March 6, 2019
Medical specialties, Surgery, PLIF, Medicine, Alif, Instrumented posterior lumbar interbody fusion, Ralph Bingham Cloward

MISSION VIEJO, Calif., March 6, 2019 /PRNewswire-PRWeb/ --Amplify Surgical, Inc., a privately-held spinal device company, focusing on the development and commercialization of minimally-invasive, innovative spinal technologies, today announced the completion of several surgical cases with the dualX Dual Expanding Interbody Fusion System.

Key Points: 
  • MISSION VIEJO, Calif., March 6, 2019 /PRNewswire-PRWeb/ --Amplify Surgical, Inc., a privately-held spinal device company, focusing on the development and commercialization of minimally-invasive, innovative spinal technologies, today announced the completion of several surgical cases with the dualX Dual Expanding Interbody Fusion System.
  • Dr. Khoo also performed a two-level transforaminal lumbar interbody fusion (TLIF) procedure with two dualX devices.
  • The dualX technology is comprised of a family of titanium expandable interbody devices designed to be implanted in lateral lumbar interbody fusion (LLIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) spinal procedures.
  • The dualX Dual Expanding Interbody Fusion System is in early release and available to a select group of spine surgeons in the United States.

Inspired Spine releases study on the Clinical and Radiological outcomes of Oblique Lateral Lumbar Interbody Fusion

Retrieved on: 
Wednesday, February 13, 2019
Medical specialties, Surgery, Medicine, PLIF, Human back, Spinal fusion, Neurosurgery, Vertebral column, Instrumented posterior lumbar interbody fusion, Ralph Bingham Cloward

BURNSVILLE, Minn., Feb. 13, 2019 /PRNewswire/ --Inspired Spine's Dr. H. Abbasi has released an innovative study presenting clinical, and radiological outcomes including fusion rates for oblique lateral lumbar interbody fusion (OLLIF).

Key Points: 
  • BURNSVILLE, Minn., Feb. 13, 2019 /PRNewswire/ --Inspired Spine's Dr. H. Abbasi has released an innovative study presenting clinical, and radiological outcomes including fusion rates for oblique lateral lumbar interbody fusion (OLLIF).
  • These studies included Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF), a recent innovation in MI Spinal Fusion, and Oblique Lateral Lumbar Interbody Fusion (OLLIF).
  • Inspired Spine is a Minnesota based, innovative total spine health company, that offers procedures that optimize the way lumbar fusions are performed.
  • To date, Inspired Spine surgeons have performed almost 1000 OLLIF procedures to successfully treat many lumbar spine conditions.

Nanovis Expands the Range of Footprints for its Signature FortiCore Posterior Lumbar Interbody Fusion System

Retrieved on: 
Wednesday, November 14, 2018
Medical Subject Headings, Medical classification, Irregular bones, Skeletal system, Vertebrate anatomy, PLIF, Human back, Vertebral column, Vertebra, Cervical vertebrae, Instrumented posterior lumbar interbody fusion

CARMEL, Ind, Nov. 14, 2018 /PRNewswire-PRWeb/ -- Nanovis , a leader in nanomedicine for the spine, today announced adding 22mm and 25mm lengths to its FortiCore rotatable Posterior Lumbar Interbody Fusion (PLIF) devices.

Key Points: 
  • CARMEL, Ind, Nov. 14, 2018 /PRNewswire-PRWeb/ -- Nanovis , a leader in nanomedicine for the spine, today announced adding 22mm and 25mm lengths to its FortiCore rotatable Posterior Lumbar Interbody Fusion (PLIF) devices.
  • "Many of our customers asked for these new sizes so they could treat their lumbar patients after using FortiCore in the cervical spine.
  • They've been very pleased with their patient's results and are asking for more lumbar FortiCore options because of the difficulties in assessing and achieving the best outcomes with other interbody technologies."
  • FortiCore interbody fusion devices are comprised of a deeply porous titanium scaffold designed to assist in securing the implant in the intervertebral space.

Innovasive™ Granted FDA Clearance for DualX™ Expanding Interbody Spinal Device

Retrieved on: 
Wednesday, October 31, 2018
Medical Subject Headings, Medical classification, Medicine, PLIF, Human back, Spinal fusion, Alif, Vertebral column, Instrumented posterior lumbar interbody fusion

MISSION VIEJO, Calif., Oct. 31, 2018 /PRNewswire-PRWeb/ --Innovasive, a privately-held spinal device company, focuses on developing and commercializing minimally-invasive, innovative spinal technologies.

Key Points: 
  • MISSION VIEJO, Calif., Oct. 31, 2018 /PRNewswire-PRWeb/ --Innovasive, a privately-held spinal device company, focuses on developing and commercializing minimally-invasive, innovative spinal technologies.
  • Today, Innovasive announced that they have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market their DualX technology, a titanium, dual expanding, interbody device for spinal fusion procedures in the lumbar spine.
  • "DualX is a unique expandable interbody that expands in two independent directions," explained Andy Choi, Chief Executive Officer, Innovasive, Inc. "First, it expands laterally to provide a wide base for stability and spinal support.
  • The DualX technology is comprised of a family of titanium expandable interbody devices designed to be used in transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF) and lateral lumbar interbody fusion (LLIF) spinal procedures.

Renovis Surgical Receives FDA Clearance for Tesera Trabecular Technology 3D-Printed Lateral Interbody Fusion System

Retrieved on: 
Wednesday, September 26, 2018
Anatomy, PLIF, Alif, Titanium alloy, Bone

REDLANDS, Calif. andAUSTIN, Texas, Sept. 26, 2018 /PRNewswire/ --Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera X Lateral Interbody Fusion System.

Key Points: 
  • REDLANDS, Calif. andAUSTIN, Texas, Sept. 26, 2018 /PRNewswire/ --Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera X Lateral Interbody Fusion System.
  • Tesera X is the latest product to utilize Renovis' proprietary 3D-printed porous architecture, which is made using additively manufactured titanium alloy, and features a low modulus, load-sharing design with a randomized pore structure to mimic cancellous bone.
  • A 550-micron average pore size and 68% porosity combined with micro-surface roughness within the structure makes for an ideal environment for bone ongrowth and ingrowth.
  • Tesera X completes Renovis' 3D-printed titanium interbody product portfolio, which also includes implants for ALIF, TLIF, PLIF, ACDF, and standalones.

Global Spinal Fusion Market 2013-2017 & 2018-2023

Retrieved on: 
Monday, June 25, 2018
Medicine, Surgery, Clinical medicine, PLIF, Minimally-invasive surgery, Spinal fusion, Alif, Minimally invasive procedures, Neurosurgery, Tethered spinal cord syndrome

The "Global Spinal Fusion Market: By Procedure - Traditional (ALIF, PLIF, Others), Minimally Invasive (MITLIF, XLIF, Others), By Region, By Country (2018 Edition)- Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Spinal Fusion Market: By Procedure - Traditional (ALIF, PLIF, Others), Minimally Invasive (MITLIF, XLIF, Others), By Region, By Country (2018 Edition)- Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
  • Over the recent years, global spinal fusion market has been witnessing growth, on account of several driving factors including rising healthcare awareness amongst consumers, surging prevalence of spinal deformities due to accidents along with increasing health expenditure in developing countries.
  • Moreover, ongoing demographic shift towards geriatric population with significant population suffering from inveterate spinal ailments, is expected to propel the demand for spinal fusion surgeries.
  • Global Spinal Fusion Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
    Spinal Fusion Market - Size and Growth: By Value
    By Procedure Type - Traditional and Minimally Invasive: By Value
    By Traditional Spinal Fusion Sub-Type - ALIF, PLIF and Others: By Value
    By Minimally Invasive Spinal Fusion Sub-Type - TLIF, XLIF and Others: By Value